[DISCLOSURE]
Green Cross Medical Science (142280) announced on June 14 that it has received a 23.14 billion won (US$20.58 million) order from Korean Red Cross to supply nucleic acid amplification testers.
This amounts to 26.68 percent of its 2016 revenue and the contract is valid until Dec. 14, 2018.
By Hwang You-mee (
theinvestor@heraldcorp.com)